RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 840 filers reported holding RAYTHEON CO in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $881,000 | -4.4% | 5,065 | 0.0% | 0.37% | +17.6% |
| Q1 2019 | $922,000 | +18.7% | 5,065 | 0.0% | 0.31% | +6.8% |
| Q4 2018 | $777,000 | -60.9% | 5,065 | -72.2% | 0.29% | -61.7% |
| Q3 2015 | $1,987,000 | +14.2% | 18,187 | 0.0% | 0.76% | +26.2% |
| Q2 2015 | $1,740,000 | -16.4% | 18,187 | -5.5% | 0.61% | -15.5% |
| Q4 2014 | $2,082,000 | -4.3% | 19,245 | -10.1% | 0.72% | -33.6% |
| Q3 2014 | $2,175,000 | +10.2% | 21,400 | 0.0% | 1.08% | -2.4% |
| Q2 2014 | $1,974,000 | +1.7% | 21,400 | 0.0% | 1.11% | -4.2% |
| Q4 2013 | $1,941,000 | – | 21,400 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |